Non-Emergency Medical Transportation: Findings from a Return on Investment Study

An Effective Practice

Description

The study estimated the Return on Investment (ROI) of providing Non-Emergency Medical Transportation (NEMT) to dialysis and wound care appointments for diabetes. Researchers processed 2014–2015 medical, pharmacy, and long-term-care claims for members enrolled during the 24-month period for each treatment.

The average cost of one round-trip NEMT per patient is $60.24 for dialysis patients and $53.25 for would care diabetes patients. The average cost of providing NEMT per patient per month for dialysis patients is $717.25 and $291.96 for wound care diabetes patients"

Goal / Mission

The goal of this study is to examine NEMT’s return on investment and expand research on its financial benefit.

Impact

The findings suggest that NEMT more than pays for itself as part of a care management strategy for people with chronic diseases, resulting in a total positive return on investment of over $40 million per month ($480 million annually) per 30,000 Medicaid beneficiaries.

Results / Accomplishments

Providing NEMT for people with chronic conditions has a calculated positive ROI of over $40 million per month per 30,000 Medicaid beneficiaries nationally, an amount totaling to $480 million annually.

The Medicaid cost avoided because of NEMT per survey respondent per month is $3,423 for dialysis patients and $792 for would care diabetes patients. The ROI of NEMT per 10,000 dialysis patients per month is $34,229,448. The ROI of NEMT per 10,000 diabetic wound care patients per month is $7,920,635.

About this Promising Practice

Primary Contact
Tricia Beckmann
1050 K Street NW, Suite 400
Washington, DC 20001
202-312-7009
Tricia.Beckmann@faegrebd.com
Topics
Health / Health Care Access & Quality
Community / Transportation
Source
Medical Transportation Access Coalition
For more details